Literature DB >> 26489568

[Experience of the Pharmacotherapy against Appendix and Sigmoid Colon Signet Ring Cell Carcinoma with the Peritoneal Dissemination].

Shingo Harada1, Kazuhito Tsuchida, Taisuke Shibuya, Yuki Doi, Akitomo Kikuchi, Koichi Mori, Yasuhiro Yabushita, Takuo Watanabe, Hitoshi Murakami, Seiji Hasegawa, Tadao Fukushima, Hideyuki Ike, Takashi Nakayama.   

Abstract

We report 2 cases of signet ring cell carcinoma of the appendix and colon. Case 1: A 61-year-old man was admitted for lower abdominal pain. Colonoscopy revealed an elevated lesion in the orifice of the appendix. Signet ring cell carcinoma was diagnosed on biopsy. The surgical findings showed multiple peritoneal dissemination nodules, while the primary tumor was unresectable owing to extensive invasion into the retroperitoneum. The histopathological findings were signet ring cell carcinoma, T4b (retroperitoneum), NX, P3, Stage Ⅳ. Although the patient received 14 courses of treatment with S-1 as postoperative chemotherapy, he died of his illness at 32 postoperative months. Case 2: A 76-year-old man was admitted for abdominal pain. Perforation of the lower gastrointestinal tract was diagnosed on abdominal CT, and an emergency operation was performed. The surgical findings demonstrated a large number of peritoneal dissemination nodules, cecal invasion of a sigmoid tumor, and perforation of the ascending colon. The primary tumor was thought to be unresectable, and the perforated segment was resected. The histopathological findings were signet ring cell carcinoma, T4b (cecum), NX, P3, Stage Ⅳ. Although 11 courses of treatment using FOLFIRI+Bev were administered as postoperative chemotherapy, the patient died of his illness at 26 postoperative months.

Entities:  

Mesh:

Year:  2015        PMID: 26489568

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  Systemic chemotherapy combined with anti-epidermal growth factor receptor antibody therapy for RAS wild-type appendiceal signet-ring cell carcinoma: a series of three cases.

Authors:  Suguru Hirose; Chiaki Enami; Natsumi Kawamatsu; Yoshimi Ito; Tsubasa Onoda; Yutaro Sugiyama; Hirosumi Suzuki; Miho Nagafuchi; Takafumi Ikeda; Yusuke Niisato; Takeshi Yamada; Yoshiyuki Yamamoto; Toshikazu Moriwaki; Hideo Suzuki
Journal:  Int Cancer Conf J       Date:  2021-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.